Whole cohort | Systemic | Persistent oliogarthritis | Extended oligoarthritis | RF (−) polyarthritis | RF (+) polyarthritis | Enthesitis related | Psoriatic arthritis | Undifferentiated | |
---|---|---|---|---|---|---|---|---|---|
N | 352 | 28 | 164 | 13 | 67 | 11 | 16 | 28 | 25 |
JADAS-71 | |||||||||
AJC | 0.75 | 0.79 | 0.47 | 0.8 | 0.73 | 0.95 | 0.78 | 0.82 | 0.85 |
Physician global | 0.73 | 0.53 | 0.73 | 0.55 | 0.7 | 0.66 | 0.67 | 0.5 | 0.83 |
Parent global | 0.57 | 0.62 | 0.71 | 0.75 | 0.33 | 0.39 | 0.68 | 0.39 | 0.65 |
ESR | 0.53 | 0.6 | 0.33 | 0.01 | 0.48 | 0.4 | 0.43 | 0.41 | 0.69 |
LJC | 0.51 | 0.71 | 0.34 | 0.49 | 0.29 | 0.76 | 0.67 | 0.61 | 0.47 |
Pain | 0.48 | 0.37 | 0.58 | 0.57 | 0.34 | 0.04 | 0.81 | 0.47 | 0.54 |
CHAQ | 0.58 | 0.46 | 0.57 | 0.71 | 0.44 | 0.54 | 0.71 | 0.6 | 0.63 |
JADAS3-71 | |||||||||
AJC | 0.79 | 0.86 | 0.53 | 0.88 | 0.83 | 0.95 | 0.82 | 0.79 | 0.87 |
Physician global | 0.72 | 0.41 | 0.73 | 0.54 | 0.64 | 0.7 | 0.61 | 0.59 | 0.85 |
Parent global | 0.60 | 0.72 | 0.75 | 0.68 | 0.34 | 0.38 | 0.81 | 0.4 | 0.64 |
ESR | 0.33 | 0.36 | 0.1 | −0.27 | 0.22 | 0.29 | 0.16 | 0.17 | 0.62 |
LJC | 0.53 | 0.79 | 0.38 | 0.47 | 0.33 | 0.77 | 0.57 | 0.58 | 0.42 |
Pain | 0.51 | 0.46 | 0.62 | 0.54 | 0.31 | 0.1 | 0.8 | 0.48 | 0.5 |
CHAQ | 0.58 | 0.5 | 0.59 | 0.65 | 0.47 | 0.53 | 0.74 | 0.5 | 0.63 |
AJC, active joint count; CHAQ, Childhood Health Assessment Questionnaire; ESR, erythrocyte sedimentation rate; JADAS, Juvenile Arthritis Disease Activity Score; LJC, limited joint count; RF, rheumatoid factor.